One dengue dose offers children a window of protection, a Philippine study finds

In a peer-reviewed study published in Frontiers in Immunology, researchers following children in the Philippines found that a single dose of the dengue vaccine Dengvaxia was linked to a temporary reduction in infection risk, even in children who had never had dengue before. The protection fades, so it is no finish line — but understanding exactly what one dose does helps doctors design smarter, simpler vaccination schedules for dengue-prone regions.

SDG 3 · Good health and well-being — Mechanism: tech innovation